戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 te of the ACT-domain of the Escherichia coli phosphoglycerate dehydrogenase.
2                                              Phosphoglycerate Dehydrogenase 1 of the phosphorylated p
3                                Inhibition of phosphoglycerate dehydrogenase, a rate-limiting enzyme i
4 xtracts of M. maripaludis were shown to have phosphoglycerate dehydrogenase and phosphoserine aminotr
5 mes in the serine synthesis pathway, such as phosphoglycerate dehydrogenase and phosphoserine aminotr
6 1 enhances the expression of the key enzymes phosphoglycerate dehydrogenase and phosphoserine aminotr
7       The inhibition of Escherichia coli d-3-phosphoglycerate dehydrogenase by l-serine is positively
8 strongest associations were observed for D-3-phosphoglycerate dehydrogenase (D-3PGDH), cysteine and g
9 etate methyltransferase deficiency and for 3-phosphoglycerated dehydrogenase deficiency appear promis
10 intenance of the purine metabolizing enzyme, phosphoglycerate dehydrogenase, during LPS plus ATP trea
11                                          D-3-phosphoglycerate dehydrogenase (EC 1.1.1.95) from Escher
12                                          D-3-Phosphoglycerate dehydrogenase (EC 1.1.1.95) from Escher
13                                              Phosphoglycerate dehydrogenases exist in at least three
14 resents a second structural motif of the D-3-phosphoglycerate dehydrogenase family, one that contains
15                   The binding of L-serine to phosphoglycerate dehydrogenase from E. coli displays ele
16                                          d-3-Phosphoglycerate dehydrogenase from Escherichia coli con
17                                          d-3-Phosphoglycerate dehydrogenase from Escherichia coli is
18                                          D-3-Phosphoglycerate dehydrogenase from Escherichia coli is
19    The heterologously expressed and purified phosphoglycerate dehydrogenase from M. maripaludis had e
20                                          D-3-Phosphoglycerate dehydrogenase from Mycobacterium tuberc
21                 The crystal structure of D-3-phosphoglycerate dehydrogenase from Mycobacterium tuberc
22  structure of Mycobacterium tuberculosis d-3-phosphoglycerate dehydrogenase has been solved with boun
23 10 interacted with the chloroplastic protein phosphoglycerate dehydrogenase in a yeast (Saccharomyces
24                                            3-Phosphoglycerate dehydrogenase is an exclusively astrocy
25 that predicts that catalytic activity in D-3-phosphoglycerate dehydrogenase is regulated by the movem
26 tarate, facilitated by increased activity of phosphoglycerate dehydrogenase, leads to epigenetic alte
27                                          D-3-Phosphoglycerate dehydrogenase (PGDH) (EC 1.1.1.95) from
28 e catalytic activity of Escherichia coli D-3-phosphoglycerate dehydrogenase (PGDH) by binding to its
29                                              Phosphoglycerate dehydrogenase (PGDH) catalyzes the firs
30                           Escherichia coli 3-phosphoglycerate dehydrogenase (PGDH) catalyzes the firs
31                    An active conformation of phosphoglycerate dehydrogenase (PGDH) from Escherichia c
32                                          D-3-Phosphoglycerate dehydrogenase (PGDH) from Escherichia c
33 ructural homology with the ASB domain of d-3-phosphoglycerate dehydrogenase (PGDH) from Mycobacterium
34                                          D-3-Phosphoglycerate dehydrogenase (PGDH) from Mycobacterium
35 ric hybrid tetramers of Escherichia coli d-3-phosphoglycerate dehydrogenase (PGDH) have been made by
36 topped-flow analysis of Escherichia coli d-3-phosphoglycerate dehydrogenase (PGDH) reveals that the p
37 ding for the first enzyme of this pathway, 3-phosphoglycerate dehydrogenase (PGDH).
38 ol coefficient for the branch point enzyme 3-phosphoglycerate dehydrogenase (PGDH).
39 ulatory and substrate binding domains of D-3-phosphoglycerate dehydrogenase (PGDH, EC 1.1.1.95) from
40 e, we present a detailed characterization of phosphoglycerate dehydrogenases (PGDHs) as components of
41  with the ASB domain like that in type 1 D-3-phosphoglycerate dehydrogenases (PGDHs).
42     Individual gene effects were notable for phosphoglycerate dehydrogenase (PGHDH), peptidyl-prolyl
43 nately regulate expression of genes encoding phosphoglycerate dehydrogenase (PHGDH) and five downstre
44                  Enzymes of the SSP, such as phosphoglycerate dehydrogenase (PHGDH) and phosphoserine
45 anically, NAT10 promotes the expression of 3-phosphoglycerate dehydrogenase (PHGDH) and phosphoserine
46                                              Phosphoglycerate dehydrogenase (PHGDH) catalyzes the fir
47                     Astrocytes express the 3-phosphoglycerate dehydrogenase (Phgdh) enzyme required f
48 lycolysis to serine biosynthesis by inducing phosphoglycerate dehydrogenase (PHGDH) expression.
49  EVs, leading to a paracrine upregulation of phosphoglycerate dehydrogenase (PHGDH) in monocytes when
50                  Among the genes identified, phosphoglycerate dehydrogenase (PHGDH) is in a genomic r
51                                              Phosphoglycerate dehydrogenase (PHGDH) is the metabolic
52 ction of circulating serine by inhibition of phosphoglycerate dehydrogenase (PHGDH) leads to the accu
53 hat altered expression of the LOAD biomarker phosphoglycerate dehydrogenase (PHGDH) modulates AD path
54                Here we find that the loss of phosphoglycerate dehydrogenase (PHGDH) potentiates metas
55  BA, but not GH, caused a 2-fold increase in phosphoglycerate dehydrogenase (PHGDH) protein expressio
56 nificance with multiple testing adjustments, phosphoglycerate dehydrogenase (PHGDH) was the only gene
57 mes of the de novo serine synthesis pathway (phosphoglycerate dehydrogenase (PHGDH), phosphoserine am
58  acid generated by the sequential actions of phosphoglycerate dehydrogenase (PHGDH), phosphoserine am
59                                Inhibition of phosphoglycerate dehydrogenase (PHGDH), the first and ra
60                                              Phosphoglycerate dehydrogenase (PHGDH), the first rate-l
61 uman cancers often exhibit overexpression of phosphoglycerate dehydrogenase (PHGDH), the metabolic en
62 0) show that MEKi-resistant cells upregulate phosphoglycerate dehydrogenase (PHGDH), the rate-limitin
63 etween lipid metabolism and ERneg BC through phosphoglycerate dehydrogenase (PHGDH), the rate-limitin
64                            Overexpression of phosphoglycerate dehydrogenase (PHGDH), the rate-limitin
65               The gene encoding the enzyme 3-phosphoglycerate dehydrogenase (PHGDH), which catalyzes
66  4 (ATF4) and its downstream effector genes, phosphoglycerate dehydrogenase (PHGDH), which encodes a
67 d into serine and glycine metabolism through phosphoglycerate dehydrogenase (PHGDH).
68 s activity of the serine biosynthesis enzyme phosphoglycerate dehydrogenase (PHGDH).
69          Macular Muller cells expressed more phosphoglycerate dehydrogenase (PHGDH, a rate-limiting e
70                                          d-3-Phosphoglycerate dehydrogenase (Phgdh; EC 1.1.1.95) is t
71 d genes associated with serine biosynthesis (Phosphoglycerate dehydrogenase, Phgdh; phosphoserine ami
72 of residues in the regulatory domains of D-3-phosphoglycerate dehydrogenase provide the first direct
73                 The crystal structure of d-3-phosphoglycerate dehydrogenase reveals a limited number
74                                The first D-3-phosphoglycerate dehydrogenase structure to be determine
75                       In Escherichia colid-3-phosphoglycerate dehydrogenase, the amino acid sequences
76 n part to the genomic copy number gain for 3-phosphoglycerate dehydrogenase, the enzyme that controls
77                  Consistently, inhibition of phosphoglycerate dehydrogenase, the first enzyme of the
78 sphate pathway (PPP), while 2-PG activates 3-phosphoglycerate dehydrogenase to provide feedback contr
79 ns indirectly enhance the ability of SerA (3-phosphoglycerate dehydrogenase) to perform a new functio
80               Mycobacterium tuberculosis D-3-phosphoglycerate dehydrogenase undergoes significant inh
81 topped flow analysis of Escherichia coli D-3-phosphoglycerate dehydrogenase was performed by followin
82  and mice with targeted deletion of Srr or 3-Phosphoglycerate dehydrogenase, we demonstrate predomina
83             Strains lacking yggS and serA (3-phosphoglycerate dehydrogenase) were conditionally letha
84  same fold; (iii) the C-terminal domain of 3-phosphoglycerate dehydrogenase, which binds serine and i
85 e structure of a truncated form of human d-3-phosphoglycerate dehydrogenase with cofactor and a subst